title: A double-blind study comparing two single-dose regimens of ketorolac with diclofenac in pain due to cancer.
abstract: OBJECTIVE
  To compare the analgesic efficacy and safety of two single doses of ketorolac with diclofenac in acute cancer pain.
  
  
  METHODS
  Double-blind, randomized, clinical study.
  
  
  METHODS
  Hospital-based clinical research center.
  
  
  METHODS
  One hundred eighty patients suffering acute, moderate, or severe cancer pain.
  
  
  METHODS
  A single intramuscular injection of ketorolac 10 or 30 mg or diclofenac 75 mg.
  
  
  RESULTS
  Pain intensity was assessed 30 minutes and 1, 2, 3, 4, 5, and 6 hours after injection or until rescue drug administration. In approximately 70% of patients all treatments provided prompt sustained pain relief throughout the 6-hour observation period. There were no statistically significant differences in any of the analyzed efficacy measures among the three groups.
  
  
  CONCLUSIONS
  Intramuscular ketorolac 10 mg is adequate to relieve cancer pain, and is equivalent to ketorolac 30 mg and to diclofenac 75 mg.
authors.affiliation: Division of Medical Oncology, Perugia Hospital, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Minotti
authors.forename: M
authors.initials: M
authors.lastname: Betti
authors.forename: G
authors.initials: G
authors.lastname: Ciccarese
authors.forename: G
authors.initials: G
authors.lastname: Fumi
authors.forename: M
authors.initials: M
authors.lastname: Tonato
authors.forename: A
authors.initials: A
authors.lastname: Del Favero
mesh_terms: D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004008:Diclofenac / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D020910:Ketorolac; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000503:physiopathology*; D010146:Pain / Q000188:drug therapy*; D010147:Pain Measurement; D014046:Tolmetin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018712:Analgesics, Non-Narcotic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004008:Diclofenac; D014046:Tolmetin; D020910:Ketorolac